Cited by 121Retinal Diseases and TreatmentsRetinal Development and DisordersIron Metabolism and Disorders

Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD

Open access
Hadziahmetovic, Majda, Dentchev, Tzvete, Song, Ying, Haddad, Nadine, He, Xining, Hahn, Paul, Pratico, Domenico, Wen, Rong +4 more·2008·Investigative Opthalmology & Visual Science

Abstract

PURPOSE: Iron is an essential element in human metabolism but also is a potent generator of oxidative damage with levels that increase with age. Several studies suggest that iron accumulation may be a factor in age-related macular degeneration (AMD). In prior studies, both iron overload and features of AMD were identified in mice deficient in the ferroxidase ceruloplasmin (Cp) and its homologue hephaestin (Heph) (double knockout, DKO). In this study, the location and timing of iron accumulation, the rate and reproducibility of retinal degeneration, and the roles of oxidative stress and complement activation were determined. METHODS: Morphologic analysis and histochemical iron detection by Perls' staining was performed on retina sections from DKO and control mice. Immunofluorescence and immunohistochemistry were performed with antibodies detecting activated complement factor C3, transferrin receptor, L-ferritin, and macrophages. Tissue iron levels were measured by atomic absorption spectrophotometry. Isoprostane F2alpha-VI, a specific marker of oxidative stress, was quantified in the tissue by gas chromatography/mass spectrometry. RESULTS: DKOs exhibited highly reproducible age-dependent iron overload, which plateaued at 6 months of age, with subsequent progressive retinal degeneration continuing to at least 12 months. The degeneration shared some features of AMD, including RPE hypertrophy and hyperplasia, photoreceptor degeneration, subretinal neovascularization, RPE lipofuscin accumulation, oxidative stress, and complement activation. CONCLUSIONS: DKOs have age-dependent iron accumulation followed by retinal degeneration modeling some of the morphologic and molecular features of AMD. Therefore, these mice are a good platform on which to test therapeutic agents for AMD, such as antioxidants, iron chelators, and antiangiogenic agents.

Integrity signals

Registry

Crossref · 10.1167/iovs.07-1472

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence of focal CNV was present in 75% of 12-13 month-old Cp−/−Heph−/Y mice and 50% of 7-9 month-old mice.

    “Evidence of focal CNV was also present in 75% of 12–13 month-old mice and 50% of 7–9 month-old mice (Hahn et al., 2004; Hadziahmetovic et al., 2008).”

    From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Hadziahmetovic et al., 2008

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hadziahmetovic, M., Dentchev, T., Song, Y., Haddad, N., He, X., Hahn, P., Pratico, D., Wen, R., Harris, Z. L., Lambris, J. D., Beard, J., & Dunaief, J. L.
Affiliations
  • University of Pennsylvania (US)
  • Department of Pharmacology, Temple University, Philadelphia, Pennsylvania; the
  • University of Miami (US)
  • Johns Hopkins University (US)
  • Pennsylvania State University (US)
  • From the F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, and the
Venue
Investigative Opthalmology & Visual Science
Published
2008-06-01
Volume
49
Issue
6
Pages
2728
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2081933988
Cited by
121
References
46
Citations by year
2025: 3 · 2023: 1 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 3 · 2015: 14 · 2014: 12 · 2013: 6 · 2012: 14
FWCI
12.50
Type
journal article
Language
en
Open access
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Eye Institute (EY 015240, R01EY015240)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords
age-related macular degeneration, ceruloplasmin, hephaestin, iron overload, retinal degeneration, oxidative stress, complement activation, retinal pigment epithelium, photoreceptor degeneration, subretinal neovascularization, lipofuscin, isoprostanes, iron chelators, antioxidants, anti-angiogenic therapy
MeSH terms
Animals, Apoferritins, Ceruloplasmin, Choroid, Complement Activation, Complement C3, Disease Models, Animal, Iron, Macrophages, Macular Degeneration, Gas Chromatography-Mass Spectrometry, Membrane Proteins, Mice, Inbred C57BL, Pigment Epithelium of Eye, Complement Factor B, Receptors, Transferrin, Retina, Spectrophotometry, Atomic, Dinoprost, Mice, Knockout, Oxidative Stress, Iron Overload, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review